WallStreetZenWallStreetZen

NASDAQ: CERO
Cero Therapeutics Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CERO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$2.5M
Current Profit Margin
0%

CERO Return on Equity

Insufficient data to display

Be the first to know when CERO announces earnings.

CERO Return on Assets

Current Company
-23.4%
Current Industry
2.9%
CERO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CERO Return on Capital Employed

Current Company
-72.08%
Current Industry
19.5%

CERO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CERO$0.00-$2.44M-$2.54MN/AN/A
BIVI$0.00-$39.04M-$43.27MN/AN/A
RNXT$0.00-$10.12M-$10.23MN/AN/A
VINC$0.00-$39.24M-$40.16MN/AN/A
BIOR$4.00k-$113.84M-$124.12M-87.44%N/A
View Top Biotech Stocks

Cero Therapeutics Holdings Earnings & Revenue FAQ

What were CERO's earnings last quarter?

Cero Therapeutics Holdings (NASDAQ: CERO) reported Q4 2023 earnings per share (EPS) of $0.28, up 74.55% year over year. Total Cero Therapeutics Holdings earnings for the quarter were $3.49 million. In the same quarter last year, Cero Therapeutics Holdings's earnings per share (EPS) was $1.10.

If you're new to stock investing, here's how to buy Cero Therapeutics Holdings stock.

What was CERO's earnings growth in the past year?

As of Q2 2024, Cero Therapeutics Holdings's earnings has grown year over year. Cero Therapeutics Holdings's earnings in the past year totalled -$2.54 million.

What was CERO's revenue last quarter?

Cero Therapeutics Holdings (NASDAQ: CERO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cero Therapeutics Holdings's revenue was $0.00.

What was CERO's revenue growth in the past year?

As of Q2 2024, Cero Therapeutics Holdings's revenue has grown null year over year. Cero Therapeutics Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.